Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 250

1.

Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children.

Hallander HO, Paniagua M, Espinoza F, Askelöf P, Corrales E, Ringman M, Storsaeter J.

Vaccine. 2002 Nov 22;21(1-2):138-45.

PMID:
12443672
[PubMed - indexed for MEDLINE]
2.

Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.

Concha A, Giraldo A, Castañeda E, Martínez M, de la Hoz F, Rivas F, Depetris A, Svennerholm AM, Sack DA.

Bull Pan Am Health Organ. 1995 Dec;29(4):312-21.

PMID:
8605522
[PubMed - indexed for MEDLINE]
3.

Safety, immunogenicity, and lot stability of the whole cell/recombinant B subunit (WC/rCTB) cholera vaccine in Peruvian adults and children.

Taylor DN, Cárdenas V, Perez J, Puga R, Svennerholm AM.

Am J Trop Med Hyg. 1999 Dec;61(6):869-73.

PMID:
10674661
[PubMed - indexed for MEDLINE]
Free Article
4.

Antibody responses after immunization with killed oral cholera vaccines during the 1985 vaccine field trial in Bangladesh.

Sack DA, Clemens JD, Huda S, Harris JR, Khan MR, Chakraborty J, Yunus M, Gomes J, Siddique O, Ahmed F, et al.

J Infect Dis. 1991 Aug;164(2):407-11.

PMID:
1856488
[PubMed - indexed for MEDLINE]
5.

Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.

Trach DD, Cam PD, Ke NT, Rao MR, Dinh D, Hang PV, Hung NV, Canh DG, Thiem VD, Naficy A, Ivanoff B, Svennerholm AM, Holmgren J, Clemens JD.

Bull World Health Organ. 2002;80(1):2-8.

PMID:
11884967
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines.

Clemens JD, Sack DA, Chakraborty J, Rao MR, Ahmed F, Harris JR, van Loon F, Khan MR, Yunis M, Huda S, et al.

Vaccine. 1990 Oct;8(5):469-72.

PMID:
2251873
[PubMed - indexed for MEDLINE]
7.

Immunological memory after immunization with oral cholera B subunit--whole-cell vaccine in Swedish volunteers.

Jertborn M, Svennerholm AM, Holmgren J.

Vaccine. 1994 Sep;12(12):1078-82.

PMID:
7998416
[PubMed - indexed for MEDLINE]
8.

Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.

Shamsuzzaman S, Ahmed T, Mannoor K, Begum YA, Bardhan PK, Sack RB, Sack DA, Svennerholm AM, Holmgren J, Qadri F.

Vaccine. 2009 Feb 25;27(9):1386-92. doi: 10.1016/j.vaccine.2008.12.041. Epub 2009 Jan 13.

PMID:
19146897
[PubMed - indexed for MEDLINE]
9.

Immunogenicity of two formulations of oral cholera vaccine comprised of killed whole vibrios and the B subunit of cholera toxin.

Migasena S, Desakorn V, Suntharasamai P, Pitisuttitham P, Prayurahong B, Supanaranond W, Black RE.

Infect Immun. 1989 Jan;57(1):117-20.

PMID:
2909484
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Impaired immune response to natural infection as a correlate of vaccine failure in a field trial of killed oral cholera vaccines.

Clemens J, Rao M, Sack D, Ahmed F, Khan MR, Chakraborty J, Kay B, Huda S, Yunus M, van Loon F, et al.

Am J Epidemiol. 1995 Oct 1;142(7):759-64.

PMID:
7572947
[PubMed - indexed for MEDLINE]
11.

Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age.

Saha A, Chowdhury MI, Khanam F, Bhuiyan MS, Chowdhury F, Khan AI, Khan IA, Clemens J, Ali M, Cravioto A, Qadri F.

Vaccine. 2011 Oct 26;29(46):8285-92. doi: 10.1016/j.vaccine.2011.08.108. Epub 2011 Sep 9.

PMID:
21907255
[PubMed - indexed for MEDLINE]
12.

Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease.

Jertborn M, Svennerholm AM, Holmgren J.

J Clin Microbiol. 1986 Aug;24(2):203-9.

PMID:
3528211
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial.

Kanungo S, Paisley A, Lopez AL, Bhattacharya M, Manna B, Kim DR, Han SH, Attridge S, Carbis R, Rao R, Holmgren J, Clemens JD, Sur D.

Vaccine. 2009 Nov 16;27(49):6887-93. doi: 10.1016/j.vaccine.2009.09.008. Epub 2009 Sep 15.

PMID:
19761838
[PubMed - indexed for MEDLINE]
14.

Formulation in tablets of a cholera whole cells inactivated vaccine candidate.

Talavera A, Año G, Pino Y, Castaño J, Uribarri E, Riverón L, Gil S, Fernández S, Cedré B, Valmaseda T, Pérez JL, Infante JF, García L, Sierra G.

Vaccine. 2006 Apr 12;24(16):3381-7. Epub 2006 Jan 19.

PMID:
16460846
[PubMed - indexed for MEDLINE]
15.

Immunological response to Vibrio cholerae O1 infection and an oral cholera vaccine among Peruvians.

Sanchez JL, Hayashi KE, Kruger HF, Meza R, English CK, Vidal W, Svennerholm AM, Taylor DN.

Trans R Soc Trop Med Hyg. 1995 Sep-Oct;89(5):542-5.

PMID:
8560536
[PubMed - indexed for MEDLINE]
16.

Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group.

Savarino SJ, Hall ER, Bassily S, Brown FM, Youssef F, Wierzba TF, Peruski L, El-Masry NA, Safwat M, Rao M, El Mohamady H, Abu-Elyazeed R, Naficy A, Svennerholm AM, Jertborn M, Lee YJ, Clemens JD.

J Infect Dis. 1999 Jan;179(1):107-14.

PMID:
9841829
[PubMed - indexed for MEDLINE]
Free Article
17.

Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.

Leung DT, Rahman MA, Mohasin M, Patel SM, Aktar A, Khanam F, Uddin T, Riyadh MA, Saha A, Alam MM, Chowdhury F, Khan AI, Charles R, LaRocque R, Harris JB, Calderwood SB, Qadri F, Ryan ET.

Clin Vaccine Immunol. 2012 May;19(5):690-8. doi: 10.1128/CVI.05615-11. Epub 2012 Mar 21. Erratum in: Clin Vaccine Immunol. 2012 Aug;19(8):1337.

PMID:
22441386
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles.

Yeh MK, Liu YT, Chen JL, Chiang CH.

J Control Release. 2002 Aug 21;82(2-3):237-47.

PMID:
12175740
[PubMed - indexed for MEDLINE]
19.

Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial.

Sur D, Lopez AL, Kanungo S, Paisley A, Manna B, Ali M, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Donner A, Ganguly NK, Nair GB, Bhattacharya SK, Clemens JD.

Lancet. 2009 Nov 14;374(9702):1694-702. doi: 10.1016/S0140-6736(09)61297-6. Epub 2009 Oct 8. Erratum in: Lancet. 2010 Oct 23;376(9750):1392.

PMID:
19819004
[PubMed - indexed for MEDLINE]
20.

Immunologic response to oral cholera vaccination in a crossover study: a novel placebo effect.

Wasserman SS, Kotloff KL, Losonsky GA, Levine MM.

Am J Epidemiol. 1993 Dec 1;138(11):988-93.

PMID:
8256784
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk